Financial Times:

Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences  —  Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences

Financial Times:

Sources: Dassault Systèmes is in talks to buy drug trial software maker ArisGlobal from Nordic Capital for about $2B, extending its push into life sciences  —  Potential purchase of ArisGlobal from Swedish buyout group would boost French conglomerate's push into life sciences

Source: TechMeme
Source Link: https://www.techmeme.com/260716/p62#a260716p62